Noopept — Deep Research (Cognitive & Nootropic)

Published · Researched 2026-09-21

Research file written 2026-09-21. Social-first methodology: community sources weighted before vendor pages.

Classification note: Noopept is a synthetic dipeptide mimetic / dipeptide-derived compound, not a classic peptide. It is N-phenylacetyl-L-prolylglycine ethyl ester (omberacetam), CAS 157115-85-0 — a piracetam-derived proline-containing dipeptide analog. It is included in this peptide category as a community staple: it is discussed, stacked, and sold alongside the nootropic peptides (including in combination logs with Dihexa and Cerebrolysin), and any peptide-buyer guide that omitted it would be incomplete. Do not describe it as a classic peptide.

1. Overview

Noopept (omberacetam) is the workhorse nootropic of the post-Soviet pharmacopoeia: developed in Russia, registered as a medicine in Russia for cognitive impairment, and sold in the West as capsules or powder through gray-market nootropic vendors. Chemically it is a dipeptide analog of the racetam family, studied for effects on glutamatergic (AMPA/NMDA modulation) and cholinergic signaling, neuroplasticity, and neuroprotection in experimental models. It has high oral bioavailability and rapid hydrolysis into bioactive peptide fragments — one reason it is dosed in milligrams (typically 10 mg once or twice daily in community discussion) rather than the tens-of-milligrams of classic racetams.

It is the category's highest-volume, longest-discussed compound, with a forum and vendor-review record stretching back over a decade and genuinely split verdicts.

2. Social standing

One of the strongest, most contested anecdote trails in nootropics:

• Forums (Longecity, ProfessionalMuscle, Reddit r/Nootropics): long-term experience threads. Common praise: clear-headed focus, memory, verbal fluency, processing speed. Common negatives: headaches, restlessness, dizziness, irritability, overstimulation; a meaningful minority report no effect at all. One long-term Longecity account reported unusually intense mood/music/social-perception effects and some tolerance — treat as a single striking anecdote, not a typical outcome.
• Vendor reviews (CosmicNootropic, 2025 verified-buyer examples): the full spread in one place — immediate benefit through no effect after escalating from 5 to 15 mg.
• Community dose folklore: commonly centers on 10 mg once or twice daily — community consensus, not medical guidance. Stacking with a choline source (Alpha-GPC, CDP-choline) is the standard community advice to counter the headache issue.
• Combination logs: appears in multi-compound logs with Dihexa and Cerebrolysin (Evolutionary.org health-improvement log), i.e., it is part of the peptide community's actual stack vocabulary.
• Overhyped warnings: "non-toxic at any dose" style claims are false confidence — human data is limited, long-term safety data in healthy users is thin, and the overstimulation/irritability reports are real. Potency makes precise dosing matter.

3. Social validation — Tier 2 (strong independent evidence on forums + vendor reviews; Meta-platform owner content thin)

• Longecity / ProfessionalMuscle / Reddit experience threads (years of posts): prove sustained, large-scale real-world use with a genuinely split verdict — the strongest form of community validation this category offers. Proves Noopept is a lived-with compound, not a marketing artifact.
• CosmicNootropic verified-buyer reviews (2025): prove the current retail market is active and that the response spread (benefit to non-response) is real and recent.
• Evolutionary.org multi-compound logs: prove Noopept is stacked alongside Dihexa and Cerebrolysin in actual self-experimentation protocols. Proves peptide-community integration.
• Nootropicology and vendor research summaries: prove the preclinical/human-research file exists (Russian clinical work on cognitive impairment) — modest but real, unlike the frontier compounds.
• Gap: no named Facebook Group posts or Threads owner content surfaced this round; the validation rests on forums and vendor reviews rather than the Meta platforms. Flagged honestly.

4. Key specs table

5. Pricing (observed 2026-09-21)

Marketplace used range: not observed — report honestly, no used-market data found. Noopept is the category's price outlier in the other direction: ~$25 for a two-month supply at community doses makes it roughly an order of magnitude cheaper per month than any true peptide in this track.

6. What's included / what's needed

• Capsules are ready to use; no reconstitution, no syringes — the only compound in this category sold as a conventional oral supplement format.
• Community stack advice: a choline source alongside it (separate purchase).

7. Support reality

• COA culture: weaker than the peptide-vial market — capsule sellers vary in published testing; SwissChems and NextChems advertise ≥99% purity verification, but the Etsy/eBay tier is buyer-beware.
• Regulatory gray zone: sold as "research use only" by US vendors while simultaneously marketed with supplement-style dosing language — the dual positioning is itself a red flag for QA consistency.
• Quality risk: the cheapest listings (Etsy, eBay powder) carry the highest identity/purity risk; powder from non-specialist sellers has no chain of custody.

8. Community verdict

Noopept is the category's honest workhorse: cheap, widely tried, genuinely split in outcome. The community's settled view is that it is a real cognitive tool for a subset of users (focus, verbal fluency, memory), a headache machine for another subset (fixable with choline, per folklore), and a non-event for a third. It is the only item in this track with a decade of user data — which is exactly why its risks (overstimulation, irritability, unknown long-term profile in healthy users) are also the best documented.

9. Regulatory & safety status

• Russia: registered medicine (prescription) for cognitive impairment — the only item in this track besides Semax/Selank/Cerebrolysin/Cortexin with a real medical registration anywhere.
• USA: not FDA approved; sold as research chemical / gray-market supplement. Not evaluated by the FDA for any use.
• EU/UK: not EMA approved; unregulated gray-market product.
• Community-reported side effects: headaches (most common, cholinergic-linked per community theory), irritability, restlessness, dizziness, overstimulation, sleep disturbance; blood-pressure/mood effects in sensitive individuals (vendor/community pages). Limited long-term human data in healthy users.

Images

5/8 views present in img/: noopept-side.jpg, noopept-top.jpg, noopept-detail.jpg, noopept-scale.jpg, noopept-box.jpg. All verified valid JPEGs. Missing views: hero, rear, in-use/owner photo — no distinct real photos found for these views; named honestly.

Not medical advice. This is community research, not a recommendation. Noopept is not FDA/EMA approved; gray-market products carry quality and labeling risks. Talk to a clinician before considering any nootropic.

Named sources

• Forum consensus — Community-reported dose: 10 mg 1–2×/day; some escalate 5→15 mg — not medical guidance
• Community consensus — Stack folklore: Pair with choline donor (Alpha-GPC/CDP-choline) to counter headaches
• Vendor/community pages — Cycle folklore: 4–12 weeks on, then break — not medical guidance
• Nootropicology — Human research: Russian clinical work on cognitive impairment; limited Western data
• Vendor review — **Vendor reviews (CosmicNootropic, 2025 verified-buyer examples):** the full spread in one place — immediate benefit through no effect after escalating from 5 to 15 mg. (2025)
• Forums (Longecity, ProfessionalMuscle, Reddit r/Nootropics) — long-term experience threads.
• Vendor reviews (CosmicNootropic, 2025 verified-buyer examples) — the full spread in one place — immediate benefit through no effect after escalating from 5 to 15 mg. (2025)
• Longecity / ProfessionalMuscle / Reddit experience threads (years of posts) — prove sustained, large-scale real-world use with a genuinely split verdict — the strongest form of community validation this category offers.
• CosmicNootropic verified-buyer reviews (2025) — prove the current retail market is active and that the response spread (benefit to non-response) is real and recent. (2025)

Source URLs were not recorded for these references.